FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Bupivacaine HCl Inj Recall

Bupivacaine HCl Inj

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Sep 24, 2014
Recall ID
D-1588-2014
Check your lot numberHow we source this data

Summary

Hospira recalled Bupivacaine HCl Inj starting Sep 4, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1588-2014 on Sep 24, 2014. Reason: Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.

Product description

Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free, For Nerve Block, Caudal, and Epidural Anesthesia, Not for Spinal Anesthesia, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1162-02

Lot numbers, UPCs & expiration codes

LOT 37-268-DK; Exp: 1JAN2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1588-2014
Classification
Class II
Status
Terminated
Recall initiated
Sep 4, 2014
FDA report date
Sep 24, 2014
Quantity
75,000 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1588-2014, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
69247
Address
275 N Field Dr
Code information
LOT 37-268-DK; Exp: 1JAN2016
Postal code
60045-2579
Report date
Sep 24, 2014
Product type
Drugs
Recall number
D-1588-2014
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
75,000 vials
Termination date
Jul 23, 2015
Reason for recall
Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free, For Nerve Block, Caudal, and Epidural Anesthesia, Not for Spinal Anesthesia, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1162-02
Distribution pattern
Nationwide
Recall initiation date
Sep 4, 2014
Initial firm notification
Letter
Center classification date
Sep 17, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1588-2014, published Sep 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls